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Abstract: Arsenic is a toxic metalloid that causes skin cancer and binds to cysteine residues—a property that could be used to infer arsenic 
responsiveness of a target protein. Non-synonymous Single Nucleotide Polymorphisms (nsSNPs) result in amino acid substitutions and 
may alter arsenic binding with cysteine residues. Thus, the objective of this investigation was to identify and analyze nsSNPs that lead 
to substitutions to or from cysteine residues as an indication of increased or decreased arsenic responsiveness. We hypothesize that 
integration of data on molecular impacts of nsSNPs and arsenic-gene relationships will identify nsSNPs that could serve as arsenic 
responsiveness markers. We have analyzed functional and structural impacts data for 5,811 nsSNPs linked to 1,224 arsenic-annotated 
genes. In addition to the identified candidate nsSNPs for increased or reduced arsenic responsiveness, we observed i) a nsSNP that 
results in the breakage of a disulfide bond, as candidate marker for reduced arsenic responsiveness of KLK7, a secreted serine protease 
participate in normal shedding of the skin; and ii) 6 pairs of vicinal cysteines in KLK7 protein that could be binding sites for arsenic. 
In summary, our analysis identified non-synonymous SNPs that could be used to evaluate responsiveness of a protein target to arsenic. 
In particular, an epidermal expressed serine protease with crucial function in normal skin physiology was prioritized on the basis of 
abundance of vicinal cysteines for further research on arsenic-induced keratinocyte carcinogenesis.
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Arsenic  (As)  is  recognized  as  an  environmental 
toxicant  of  concern  for  global  public  health  and 
a  leading  cause  of  toxicity  and  carcinogenicity.1,2 
Arsenic  targets  the  human  skin  and  long-term 
exposure  to  arsenic,  principally  through  drinking 
water, has been correlated with increased risk of skin 
cancer.3–5 The cellular toxicity of arsenic has been well 
documented from case studies of poisoning incidents 
and  medicinal  use.2,6  However,  due  to  increased 
epidemiological  reports  of  arsenic  related  cancers 
in  places  such  as  Southeastern  Michigan  (USA), 
Taiwan, China, India and Bangladesh, public health 
concerns about long-term exposure have arisen.2,6–8 
Inorganic arsenic is classified by the United States 
Environmental Protection Agency (U.S. EPA) as a 
Group A carcinogen based on sufficient evidence of 
carcinogenicity in humans.9 Chronic oral exposure to 
inorganic arsenic can have adverse effects on tissues 
in the human body systems.10 However, the human 
skin is the critical organ of arsenic toxicity because 
arsenic has a strong affinity for the keratin proteins 
which  are  rich  in  the  sulphur  containing  cysteine 
residues.11–13  Chronic  exposure  to  arsenic  induces 
sequential changes in the skin epithelium, proceed-
ing from hypopigmentation to hyperkeratosis which 
may eventually lead to skin cancer.11 Arsenic-induced 
skin lesions are early warning markers for develop-
ment of cancers in internal organs.14,15 A well-known 
beneficial use of arsenic is that arsenic trioxide is used 
for treatment of relapsed or refractory acute promy-
elocytic leukemia.16–20 However, side effects of treat-
ment with arsenic trioxide include significant adverse 
cardiac effects.21
The  avalanche  of  genome  sequences  combined 
with genome-enabled datasets from high-throughput 
gene expression, genotyping, haplotyping and pro  tein 
assays is making it possible to gain biological insights 
into previously unknown gene-toxicant interactions. 
Arsenicogenomics,  an  aspect  of  toxicogenomics, 
therefore, provides a means to i)   understand how vari-
ous genes respond to arsenic and ii) how arsenic mod-
ifies the function and expression of specific genes in 
the genome. Early physical manifestations of arsenic 
toxicity  in  endemic  areas  are  skin  lesions  includ-
ing  melanosis  and  keratosis.  However,  not  every-
one exposed to arsenic in an endemic region would 
develop  skin  lesions.22  Therefore,  future  research 
on arsenic-induced cancers and, in particular, skin 
lesions should consider the impact of genetic varia-
tion in individual susceptibilities to arsenic toxicity.
Single  nucleotide  alterations  in  the  DNA 
sequence  represent  a  major  source  of  genetic 
heterogeneity23  and  the  most  common  type  of 
genetic variation in the human genome. The diver-
sity  of  single  nucleotide  polymorphisms  (SNPs) 
derived  from  arsenic  responsive  genes  in  differ-
ent  populations  could    provide  biomarkers  for  an 
individual’s  susceptibility  to  arsenic-induced  dis-
eases. Genomic and bioinformatics techniques now 
exist to identify and analyze the presence of SNPs 
in populations.24 Furthermore, the dense distribu-
tion of SNPs across the genome makes them ideal 
markers  for  large-scale  genome-wide  association 
studies to discover genes in common complex dis-
eases, such as cancer. A SNP-  induced amino acid 
substitution  in  the  coding  region  can  be  broadly 
divided  into  synonymous  (no  change  in  amino 
acid) or non-synonymous (change in amino acid).25 
Furthermore, the functional impact of the SNP on 
protein function has been described as deleterious 
(disruptive)  or  non-deleterious  (benign/neutral).26 
Non-synonymous  substitutions  could  lead  to 
missense  or  nonsense  mutations  in  the  encoded 
polypeptide. In particular, nonsense mutations that 
generate premature termination codons (PTCs) are 
responsible for approximately one-third of human 
genetic diseases.27 In addition, substitutions in one 
or two amino acids of a protein sequence can alter 
the quantity of encoded protein during expression in 
mammalian cells.28 Considering that arsenic trioxide 
is also used for treatment of acute promyelocytic 
leukemia,16,18,19,29 genetic variation may also affect 
response to therapy.
Arsenic  binds  to  sulfhydryl  (SH)  groups  of 
cysteine  (Cys)  residues  to  form  arsenic-thiol 
linkages,  a  property  that  could  be  used  to  infer 
arsenic  responsiveness  of  a  protein  target  as  well 
as  contribute  to  oxidative  and  protein  folding 
stresses.30–32 In the human arsenic (+3 oxidation state) 
methyltransferase (hAS3MT) sequence, Cys residues 
at positions 156, 206 and 250 play important roles   
in the enzymatic function and structure.33 Mutation 
of the arsenic-sensing Cys151 in Kelch-like ECH-
associated protein 1 (Keap1) abolished arsenic acti-
vation of nuclear factor erythroid 2-related factor 2, 
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antioxidative cytoprotective genes.34
Non-synonymous  Single  Nucleotide  Polymor-
phisms (nsSNPs) result in amino acid substitutions and 
may alter the number of cysteine residues available to 
arsenic for binding to a protein cellular target. There-
fore, the objective of this investigation was to identify 
and analyze nsSNPs that lead to substitutions to or 
from cysteine residues as an indication of increased 
or decreased arsenic responsiveness of a protein. We 
hypothesize  that  integration  of  data  on  molecular 
impacts  of  non-synonymous  single  nucleotide 
polymorphisms  and  arsenic-gene  relationships  will 
help  identify  nsSNPs  that  are  candidate  arsenic 
responsiveness markers.
An  integrative  approach  combining  results  from 
selected  web-based  toxicogenomics  and  genomics 
databases  as  well  as  bioinformatics  tools  was  used 
to  prioritize  candidate  nsSNPs  markers  for  arsenic 
responsiveness  of  protein  targets.  In  the  first  step, 
a  list  of  genes  annotated  to  interact  with  arsenicals 
was retrieved from the Comparative Toxicogenomics 
Database.35 Subsequently, the nsSNPs linked to these 
arsenic-annotated genes were extracted from SNPs3D36 
and analyzed for functional and structural impacts data 
on protein isoforms. Significant amino acid substitu-
tions to or from cysteine residues were then prioritized 
based on structural effect resulting in breakage of a 
disulphide bond as well as function in skin cells. Fur-
thermore, structural homology modeling was used to 
identify  vicinal  (neigboring)  cysteines  in  prioritized 
protein targets of arsenic. In order to facilitate addi-
tional investigations on prioritized SNPs, protein tar-
gets and molecular mechanisms of arsenic action, we 
have constructed a collection of over 100,000 sentences 
from  over  16,000  PubMed37  abstracts  on  arsenic. 
Finally, a web resource Arsenic Sentence Database was 
developed to enable web-based search of the sentences 
by keywords and PubMed identifiers.
Methods
Functional and structural impacts  
of single nucleotide polymorphisms  
on arsenic annotated genes
The molecular functional effects of non-synonymous 
SNPs  based  on  sequence  and  structure  analysis 
were retrieved from the SNPs3D web resource and 
database36  for  genes  curated  in  the  Comparative 
Toxicogenomics  Database  (CTD)35  to  have  a  rela - 
tionship  with  arsenic.  In  the  CTD,  the  term  gene 
also  includes  mRNA  and  proteins.  We  described 
  relationship in terms of arsenic modifying the function 
and/or expression of genes. Furthermore, we referred 
to the genes as arsenic-responsive genes or proteins. 
In SNPs3D, the classification into in vivo functional 
impact categories of the SNP was based on two Sup- 
port Vector Machine (SVM) models: protein sequence 
conservation profiling and protein structure stability. 
In both machine learning models, an SVM is trained 
using 5 sequence profiles and 15 protein stability fea-
tures. Additional details on the methods are available 
at the SNPs3D website http://www.snps3d.org/help/
method.html. The nsSNPs were ranked according to 
SVM score. For both sequence and structure SVM 
scores, a nsSNP with negative score was classified 
as deleterious while a nsSNP with a positive score 
was classifed as non-  deleterious. We observed that 
some  nsSNPs  in  SNPs3D  were  assigned  a  SVM 
score of -0.00. However, they were not tagged as 
deleterious. Thus, these nsSNP were classified in this 
investigation as non-  deleterious. Furthermore, High 
Confidence (HC) SVM scores were greater than 0.50 
or less than -0.50.38
The computational workflow consisting of a suite 
of customized Perl and Unix scripts was developed to 
process results obtained from CTD and SNPs3D. The 
Entrez  Gene37  Identifiers  and  Gene  Symbols  were 
extracted  from  XML  formatted  results  of  arsenic-
gene  interactions  from  CTD.  Furthermore,  the 
Entrez Gene identifiers were then used to remotely 
download  the  SNP  Analysis  page  in  SNPs3D  for 
each CTD arsenic-annotated gene. For example, the 
SNP Analysis page for a known arsenic-interacting 
gene  Glutathione  S-transferase  Omega  1  (Gene 
  Symbol: GSTO1 and Entrez Gene Identifier: 9446) 
in  SNPs3D  is  http://www.snps3d.org/modules.php? 
name=SnpAnalysis&locus_ac=9446.
The collection of html files was processed to mine 
for relevant data to construct a dataset. The fields 
of the dataset were the dbSNP identifier,37 RefSeq 
protein isoform identifier,37 mutation, SVM sequence 
profile score, SVM structure score and description 
of impact of nsSNP on protein stability. There were 
instances that no data were predicted for the SVM 
structure  score  and  the  protein  impact.  However, 
SNPs for arsenic responsiveness
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profile. The gene symbols were also extracted from 
the CTD and combined with the dataset from SNPs3D. 
The final integrated dataset consisted of the Entrez 
Gene Identifier, Gene Symbol, the SNP Identifier, the 
Amino Acid Substitution, the SVM score computed 
for the sequence and structure profile models and the 
structural consequence of the SNP. In SNPs3D, we 
preferred  to  remotely  download  the  SNP Analysis 
pages so as to extract data and links to additional 
information such as i) sequence alignment evidence 
of tolerance of the amino acid position to mutation 
and ii) values associated with the 15 protein stability 
factors. These additional datasets were not available 
in the files available for download.
Arsenic responsiveness based  
on substitution to or from  
cysteine residues
We  conjectured  that  substitution  to  or  from  a 
cysteine residue could lead to increased or decreased 
responsiveness  of  a  protein  isoform  to  arsenic.  In 
order to identify these cysteine substitutions, a suite 
of customized Perl and Unix scripts was developed to 
extract records that met the criteria from the integrated 
CTD and SNPs3D dataset. For example, in SNPs3D 
SNP Analysis page for GSTO1, nsSNP rs45529437 
is  linked  to  substitution  from  cysteine  to  tyrosine 
in  position  32  (C32Y).  Furthermore,  rs11509436 
is linked to substitution to cysteine from serine in 
position 86 (S86C).
Structural homology modeling
Structural models of protein mutants link to candidate 
SNPs that alter arsenic responsiveness were generated 
using MODELLER 7v739 with  appropriate homologous 
high resolution X-ray crystal structure templates from 
the Protein Data Bank (PDB).40 SYBYL (Tripos Inc) 
was used to identify vicinal cysteines following a quick 
minimization routine using AMBER force field.
Construction of sentences collection 
from PubMed abstracts on arsenicals
In order to identify descriptors of interest in sentences 
and cluster sentences with identical descriptors, we 
implemented  a  sentence  splitting  algorithm  on  a 
collection of PubMed37 abstracts annotated with at 
least one of the Medical Subject Heading (MeSH) 
terms: arsenic or arsenicals. The sentence splitting 
algorithm implemented uses Perl regular expressions 
to enhance the Comprehensive Perl Archive Network 
(CPAN) Text: Sentence splitter module (http://search.
cpan.org/)  to  achieve  a  high  accuracy  in  sentence 
disambiguation. A  web  interface  for  searching  the 
catalog of sentences was also developed.
Results
Functional and structural impacts  
of single nucleotide polymorphisms  
on arsenic annotated genes
The set of genes for predicting potential responsive- 
ness to arsenic was obtained from the Comparative 
Toxicogenomics  Database  (CTD).35  A  total  of 
1,604 genes consisting of 1,492 human genes and 112 
non-human genes documented to have a relationship 
with arsenicals (Medical Subject Heading Identifier 
[MeSH ID]: D001152) were retrieved on May 10, 
2010 (Supplementary Data). We describe the gene set 
as a list of arsenic-annotated genes and their protein 
isoforms as arsenic-annotated proteins. The functional 
impacts of SNPs on protein function, as predicted by 
support vector machine (SVM), were retrieved from 
SNPs3D.36 Support Vector Machines (SVM) are super-
vised  machine  learning  techniques  that  have  been 
applied to numerous classification tasks to predict the 
class of an example based on training examples. The 
SNPs3D database provides an SVM profile score for 
the functional impact (deleterious or non deleterious) 
of an nsSNP as well as 3-dimensional protein struc-
ture of the impact of the nsSNP on protein stability. 
According to Yue et al36 the SVM used in SNPs3D is 
trained on monogenic disease data, thus deleterious 
is defined as “sufficiently damaging to protein func-
tion in vivo as to be consistent with a monogenic dis-
ease outcome”. A screenshot of a section of SNPs3D 
page for a gene is presented in Figure 1. The pages of 
the arsenic-annotated genes available in the SNPs3D 
database were the data source for extracting relevant 
data. The protein stability impacts in SNPs3D were i) 
Four classes of electrostatic interaction: reduction of 
charge–charge, charge–polar or polar–polar energy, 
or introduction of electrostatic repulsion; ii) three sol-
vation  effects:  burying  of  charge  or  polar  groups, 
and reduction in non-polar area buried on folding; 
iii) and two terms representing steric strain: backbone 
Isokpehi et al
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der Waals energy); iv) and loss of a disulfide bridge.
From  SNPs3D,  we  extracted  the  Entrez  Gene 
Identifier,  the  SNP  Identifier,  the  Amino  Acid 
Substitution and the SVM score computed for the 
sequence  and  structure  profile  models.  The  data-
set  constructed  consisted  of  5,811  nsSNPs  linked 
to  1,224  arsenic-annotated  genes.  Furthermore,  a 
total  of  8,992  nsSNP-induced  substitutions  (3,700 
deleterious,  5,292  non-deleterious)  were  linked 
to  1,872  protein  isoforms  in  the  National  Center 
for  Biotechnology  Information  (NCBI)  Reference 
Sequence Database.37 The SVM scores observed for 
the substitutions ranged from -4.73 to 6.59 with 743 
unique scores (Fig. 2). Of the 3,700 nsSNP-predicted 
substitutions,  there  were  2,739  high  confidence 
deleterious  substitutions  (SVM  sequence  profile 
score  ,-0.5)  linked  to  745  genes,  1,785  nsSNPs 
and 1,094 protein isoforms. Furthermore, there were 
4,191 high confidence non-deleterious substitutions 
(SVM  sequence  profile  score  .0.5)  linked  to 
964 genes, 2,829 and 1,459 nsSNPs. A summary of 
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Figure 1. Screenshot of a SNPs3D page for a gene. The functional and structural impacts, molecular effect and frequency of non-synonymous SNPs associated 
with the protein isoforms (RefSeq accession) is documented on the page. The negative SVM score (value in red) indicates a deleterious substitution.
Figure 2. Plot of frequencies of unique Support Vector Machine (SVM) scores for dataset of non-synonymous SNPs linked to arsenic-annotated genes. 
The SVM score predicted for each nsSNP substitution was extracted from the SNPs3D page.
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tate selection of nsSNPs according to confidence of 
SVM score, we classed substitutions into categories 
with a 0.5 interval (Table 2).
Arsenic responsiveness based on 
substitution to or from cysteine residues
A  total  of  196  nsSNPs  linked  to  144  genes  and 
225 protein isoforms were observed to cause substitu-
tions to cysteine residues. In the case of substitutions 
from cysteine residues, 92 nsSNPs linked to 79 genes 
and 122 protein isoforms were observed. In the protein 
isoforms analyzed, the substitutions to or from cysteine 
residues were restricted to the following six amino acid 
residues: Phenylalanine (F),   Glycine (G), Arginine (R), 
Serine (S), Tryptophan (W) and Tyrosine (Y).
Four classes of nsSNPs were identified on the basis 
of significant deleterious and non-deleterious effects 
on protein function as well as SNP-associated residue 
changes to or from cysteine (Table 3). The 111 nsSNPs 
that  resulted  in  non-deleterious  substitutions  to  or 
from cysteine are candidates for evaluating increased 
or  decreased  responsiveness  to  arsenic,  respectively 
(Supplementary Data). A set of nsSNPs that mutates 
the residue to or from cysteine with significant impact 
on protein function and structure (with agreement of 
both SVM scores for sequence and structure profiles) 
are presented in Table 4 and Table 5, respectively. All 
the identifiers for SNP are from the dbSNP and begin 
with “rs”.
Structural homology modeling
In SNPs3D, breakage of a disulfide bond is assigned 
to any mutation that replaces a cysteine residue in an 
S–S bond with a non-cysteine residue. Eight   nsSNPs 
from  6  genes  (9  protein  isoforms)  were  identified 
to result in breakage of a disulfide bond (Table 6). 
The impact of these nsSNPs on protein stability has 
pointed us to potential regions of arsenic binding to 
vicinal (neigboring) cysteines. Since, we are interested 
in arsenic-induced skin cancer, we further analyzed the 
Table 1. Summary of datasets.
Dataset count
Arsenic-annotated genes Retrieved  
from CTD 
1,604
Arsenic-annotated genes with nsSNPs  
in SNPs3D
1,224
Non-synonymous SNPs 5,811
Arsenic-annotated protein isoforms 1,872
Amino acid substitutions 8,992
Deleterious substitutions 3,700
Non-deleterious substitutions 5,292
High confidence deleterious substitutions* 2,739
High confidence non-deleterious  
substitutions**
4,191
SVM sequence profile score: *SVM ,-0.5; **SVM .0.5
Table 2. Distribution of SVM scores for nsSNP substitutions.
sVM score class* non-deleterious Deleterious
Frequency percent frequency Frequency percent frequency
0.0–0.5 1083 20.46% 977 26.41%
0.5–1.0 1186 22.41% 831 22.46%
1.0–1.5 1170 22.11% 627 16.95%
1.5–2.0 826 15.61% 448 12.11%
2.0–2.5 560 10.58% 348 9.41%
2.5–3.0 246 4.65% 255 6.89%
3.0–3.5 126 2.38% 132 3.57%
3.5–4.0 49 0.93% 63 1.70%
4.0–4.5 25 0.47% 18 0.49%
4.5–5.0 12 0.23% 1 0.03%
5.0–5.5 2 0.04%
5.5–6.0 3 0.06%
6.0–6.5 3 0.06%
6.5–7.0 1 0.02%
note: *Absolute values.
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arsenic-annotated genes.
category  Gene 
count
snp 
count
protein 
isoforms
From Cys, deleterious 45 53 67
From Cys, non-deleterious 36 39 58
To Cys, deleterious 101 130 145
To Cys, non-deleterious 63 72 108
Table 4. Candidate nsSNPs that increase protein’s arsenic responsiveness through amino acid change to cysteine.
entrez 
gene
Gene 
symbol
nssnp protein 
isoform
Mutation sVM 
sequence 
score
sVM 
structure 
score
Impac on  
protein 
stability**
834 CASP1 3203613 NP_150635 S33C 2.76 1.33 PS
834 CASP1 3203613 NP_150634 S126C 2.36 1.33 PS
11200 CHEK2 28909981 NP_665861 S471C 2.20 1.13 PS; HBL
834 CASP1 3203613 NP_150636 S33C 1.99 1.33 PS
8644 AKR1C3 35575889 NP_003730 R170C 1.82 1.59
55713 ZNF334 41283032 NP_955473 R237C 1.71 1.08 PS
55713 ZNF334 41283032 NP_060572 R275C 1.68 1.08 PS
6389 SDHA 1041948 NP_004159 S346C 1.62 0.92 HBL
2877 GPX2 17880492 NP_002074 R146C 1.61 0.84 SBL
983 CDC2 8755 NP_203698 R59C 1.53 1.22 PS
10935 PRDX3 11554910 NP_054817 Y53C 1.19 0.99 PS
10935 PRDX3 11554910 NP_006784 Y71C 1.14 0.99 PS
5265 SERPINA1 1802962 NP_000286 S325C 0.88 1.37 PS
5265 SERPINA1 1802962 NP_001002235 S325C 0.88 1.37 PS
5265 SERPINA1 1802962 NP_001002236 S325C 0.88 1.37 PS
983 CDC2 8755 NP_001777 R59C 0.81 1.22 PS
4233 MET 34589476 NP_000236 R970C 0.77 0.99 PS
*Abbreviations: PS, On the protein surface; HBL, hydrogen bond lost; SBL, saltbridge lost.
stratum corneum chymotryptic serine protease KLK7 
  (kallikrein-related peptidase 7) for annotated structural 
consequences of SNP marker for reduced responsive-
ness, the effects of arsenic on expression as well as dis-
tribution of cysteine residues. A screenshot of SNPs3D 
page  on  structural  impact  of  nsSNP  rs17855561  is 
presented in Figure 3. The nsSNP rs17855561 in both 
KLK7 protein isoforms is predicted to result in break-
age of a disulfide bond and potentially reducing respon-
siveness to arsenic by changing the Cys in position 226 
to Tryptophan (W) (Table 6). Furthermore, according 
to data extracted from Bae et al41 by CTD curators, 
sodium  arsenite  results  in  decreased  expression  of 
KLK7 mRNA in the virally immortalized human kera-
tinocyte cell line RHEK-1. Structures of KLK7 from 
protein sequences NP_005037 and NP_644806 were 
generated using high resolution X-ray crystal structure 
of human   kallikrein (PDB ID: 2QXI).   Structural homol-
ogy models of wild type KLK7 structure revealed six 
cysteine pairs 36–165; 55–71; 137–239; 144–211; 176–
190 and 201–226 (Fig. 4).
Construction of sentence collection from 
PubMed abstracts on arsenicals
In order to facilitate further studies on these identified 
genes,  single  nucleotide  polymorphisms  and  other 
aspects of arsenic, we have segmented 16,057 PubMed 
abstracts  into  a  collection  of  108,235  sentences. 
The abstracts were selected based on annotation of 
the abstract in PubMed with at least one of the Medical 
Subject Heading (MeSH) terms: arsenic or arsenicals. 
An Arsenic Sentence Database that facilitates query 
of the sentences with keywords as well as retrieval of 
sentences for specific PubMed abstracts is available 
at http://compbio.jsums.edu/arsenic_pubmed.
The utility of the database was demonstrated by a 
search for “GSTO1” the symbol for gene encoding 
the enzyme glutathione S-transferase omega 1 which 
catalyzes the monomethyl arsenate reduction, the rate-
limiting step for inorganic arsenic biotransformation 
in humans.42,43 A cluster of 80 sentences containing the 
symbol were retrieved from the   database.   Furthermore, 
a subset of the GSTO1 sentences and containing the 
SNPs for arsenic responsiveness
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tences  from  7  PubMed  abstracts  (Table  7).  These 
abstracts were on genetic variation observed in GSTO1 
and other genes involved in arsenic metabolism.
Discussion
Since amino acid substitutions to or from cysteine 
residues attributed to SNPs might be a determinant 
of responsiveness of target proteins to arsenic and 
possibly arsenic-induced skin cancer, we undertook to 
prioritize genes and SNPs to understand keratinocyte 
carcinogenesis resulting from arsenic exposure. Our 
analysis of the functional and structural impacts of 
5,811 nsSNPs associated with 1,224 putative arse-
nic  responsive  genes  identified  i)  196  candidate 
nsSNPs  for  increased  arsenic  responsiveness  by 
substitutions to cysteine residues for 144 genes; ii) 
92 candidate nsSNP for decreased arsenic respon-
siveness  by  substitutions  from  cysteine  residues 
for 79 genes; iii) nsSNP rs17855561 that results in 
breakage of a disulfide bond, as candidate marker 
for  reduced  arsenic  responsiveness  in  KLK7,  a 
secreted serine protease that has been demonstrated 
to participate in normal shedding of the skin44 and 
iv) 6 pairs of vicinal cysteines in KLK7 protein.
The  bioinformatics  analysis  pipeline  identified 
genes  with  evidence  for  potential  SNP-induced 
increased  or  decreased  responsiveness  to  arsenic. 
To the best of our knowledge this report is the first 
large-scale  analysis  of  SNP-induced  substitutions 
evaluating  the  abundance  of  cysteines  in  putative 
protein targets of arsenic. A recent large-scale analysis 
of the curation of chemical-gene relationships from 
Table 5. Candidate nsSNPs that reduce protein’s arsenic responsiveness through amino acid change from cysteine.
entrez 
gene
Gene 
symbol
nssnp protein  
isoform
Mutation sVM  
sequence 
score
sVM  
structure 
score
Impact  
on protein 
stability*
23660 ZKSCAN5 28411998 NP_055384 C579W -3.63 -0.84 BP; OP
23660 ZKSCAN5 28411998 NP_659570 C579W -3.63 -0.84 BP; OP
7465 WEE1 17854721 NP_003381 C379R -3.62 -1.18
9753 ZSCAN12 2232432 NP_001034732 C332R -3.59 -1.11 ESR
9446 GSTO1 45529437 NP_004823 C32Y -3.53 -1.20 OP
5650 KLK7 17855561 NP_644806 C226W -2.44 -1.20 OP; BDB
5650 KLK7 17855561 NP_005037 C226W -2.43 -1.20 OP; BDB
5879 RAC1 7673785 NP_008839 C157R -2.06 -1.24 BC; OP
3945 LDHB 3575 NP_002291 C294Y -1.83 -1.05 BP; OP
5879 RAC1 7673785 NP_061485 C176R -1.77 -1.52 OP
5265 SERPINA1 8350 NP_000286 C256W -1.76 -0.51 BP
5265 SERPINA1 8350 NP_001002235 C256W -1.76 -0.51 BP
5265 SERPINA1 8350 NP_001002236 C256W -1.76 -0.51 BP
2868 GRK4 35824641 NP_892027 C215R -1.66 -0.79 ESR; OP
2868 GRK4 35824641 NP_001004057 C215R -1.55 -0.79 ESR; OP
835 CASP2 11551881 NP_116764 C370F -1.54 -0.99 OP
2868 GRK4 35824641 NP_001004056 C183R -1.51 -0.80 ESR; OP
10465 PPIH 11550298 NP_006338 C131R -1.28 -1.41 BC; ESR; OP
3107 HLA-C 41563216 NP_002108 C125R -1.15 -1.28 BC; OP; BDB
3107 HLA-C 41543517 NP_002108 C188W -0.81 -0.86 BP; OP; BDB
*Abbreviations: BP, buriedpolar; BC, buriedcharged; BDB, breakage of a disulfide bond; ESR, electrostaticrepulsion; OP, overpacking; SBL, saltbridge lost.
Table  6.  Non-synonymous  SNPs  that  predict  potential 
region of arsenic-binding to vicinal cysteines.
Gene  
symbol
nssnp protein  
isoform
Mutation
FST 1127760 NP_006341 C239S
FST 1127760 NP_037541 C239S
HLA-C 41563216 NP_002108 C125R
HLA-C 41543517 NP_002108 C188W
HLA-C 41562916 NP_002108 C188F
IL4 4986964 NP_000580 C27R
IL4 4986964 NP_758858 C27R
KLK7 17855561 NP_005037 C226W
KLK7 17855561 NP_644806 C226W
TFRC 9852079 NP_003225 C363W
TLR4 2770145 NP_612564 C306W
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whose activity were perturbed by arsenic in a vari-
ety  of  conditions  and/or  cell  types.35  Our  analysis 
extends the curation efforts by CTD by integrating 
SNP data that could help understand the molecular 
mechanisms of arsenic action in diverse cell types 
including keratinocytes.
We  have  used  the  structural  impact  annotation 
“breakage  of  a  disulfide  bond”  as  an  evidence  of 
the  presence  of  potential  arsenic-binding  vicinal 
cysteines in a protein sequence. The function and 
structure  of  proteins  are  often  determined  by  Cys 
residues  since  many  proteins  folding  are  depen-
dent on disulfide bonds.33 Arsenic binding to target 
protein  depends  on  the  number,  accessibility  and 
relative positioning of Cys residues.45 Furthermore, 
the  ability  for  trivalent  arsenicals  to  bind  to  thiol 
groups of biomolecules is an accepted mechanism 
for being more toxic than pentavalent arsenicals. The 
mRNA from the tissue serine protease KLK7 that 
was identified by our pipeline was down-regulated 
by arsenic in human keratinocyte cell line RHEK-1.41 
The proposed functions of KLK7 in the normal skin 
physiology include i) activating interleukin 1 beta 
(IL-1b) and ii) basal permeability barrier function 
of stratum corneum by degrading two major lipid 
processing  enzymes  beta-glucocerebrosidase  and 
acidic sphingomyelinase.44,46,47 The crucial function 
of  KLK7  in  normal  skin  function  and  potential 
perturbation by arsenic justifies a need to determine 
the potential energy of each Cys residues in KLK7 
combined with their proximity to enzyme active sites 
or other functional regions of the protein. We hypoth-
esize that arsenic binds to at least one of the 6 pairs of 
vicinal cysteines resulting in conformational changes 
that down regulate KLK7 function. Our hypothesis 
for KLK7 can be tested using similar experiments 
conducted to determine the role of the 8 Cys residues 
in  arsenic  binding  for  human  beta-tubulin.32  In 
this  investigation,  we  have  verified  the  sequence-
based prediction of vicinal cysteine with structural 
homology modeling.
The  functional  implications  of  SNP  modified 
polypeptides of KLK7 warrant further investigation. 
Our  text  mining  approach  using  the  gene  symbol 
GSTO1  as  a  search  term  in  a  collection  of  over 
100,000  sentences  from  over  16,000  PubMed 
abstracts  retrieved  publications  that  could  guide 
further research on the impact of arsenic as well as 
SNP- induced polymorphism on KLK7 function. In 
the case of the two enzymes Glutathione S-transferase 
omega  1  and  omega  2  (GSTO1  and  GSTO2)  that 
catalyze  mono  methyl  arsenate  reduction,  variant 
allozymes have been shown to degrade more rapidly 
than their respective wild type allozymes.48 Similar 
protein degradation experiments for KLK7, could 
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Figure 3. Screenshot of predicted structural impact of nsSNP rs17855561 on human kallikrein-7 preproprotein (NP_005037). The nsSNP results in steric 
strain (over-packing) and breakage of a disulfide bond by changing Cysteine (C) residue in position 226 to a Tryptophan (W).
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ing in susceptibility of arsenic-induced skin cancer 
in arsenicosis-endemic populations.
conclusions
Single nucleotide polymorphisms (SNPs) can alter 
the  physico-chemical  properties  of  proteins.  The 
susceptibility  to  arsenic-induced  diseases  as  well 
as response to arsenic-based drugs has been linked 
to single nucleotide polymorphisms. Our analysis 
identified  non-synonymous  SNPs  that  could  be 
used to evaluate responsiveness of a protein target 
to  arsenic.  Furthermore,  an  epidermal  expressed 
serine  protease  KLK7  with  crucial  function  in 
normal skin physiology was prioritized on the basis 
of  abundance  of  vicinal  cysteines  to  understand 
arsenic-induced keratinocyte carcinogenesis.
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